Published in Oncol Rep on January 01, 2006
Inflammation and cancer: how friendly is the relationship for cancer patients? Curr Opin Pharmacol (2009) 1.78
Inhibition of phorbol ester-induced mouse skin tumor promotion and COX-2 expression by celecoxib: C/EBP as a potential molecular target. Cancer Res Treat (2006) 0.83
Cyclin D1 expression and the inhibitory effect of celecoxib on ovarian tumor growth in vivo. Int J Mol Sci (2010) 0.80
Residual microRNA expression dictates the extent of inner ear development in conditional Dicer knockout mice. Dev Biol (2009) 1.55
Coexpression of Gas6/Axl in human ovarian cancers. Oncology (2004) 1.23
Conditional deletion of Atoh1 using Pax2-Cre results in viable mice without differentiated cochlear hair cells that have lost most of the organ of Corti. Hear Res (2010) 1.22
The molecular basis of making spiral ganglion neurons and connecting them to hair cells of the organ of Corti. Hear Res (2011) 1.18
Lmx1a is required for segregation of sensory epithelia and normal ear histogenesis and morphogenesis. Cell Tissue Res (2008) 1.17
A novel Atoh1 "self-terminating" mouse model reveals the necessity of proper Atoh1 level and duration for hair cell differentiation and viability. PLoS One (2012) 1.14
Canal cristae growth and fiber extension to the outer hair cells of the mouse ear require Prox1 activity. PLoS One (2010) 1.08
Non-steroidal anti-inflammatory drugs inhibit cellular proliferation and upregulate cyclooxygenase-2 protein expression in endometrial cancer cells. Cancer Sci (2004) 1.03
Barhl1 regulatory sequences required for cell-specific gene expression and autoregulation in the inner ear and central nervous system. Mol Cell Biol (2008) 1.00
Defects in the cerebella of conditional Neurod1 null mice correlate with effective Tg(Atoh1-cre) recombination and granule cell requirements for Neurod1 for differentiation. Cell Tissue Res (2009) 0.97
Microbiology of Bartholin's gland abscess in Japan. J Clin Microbiol (2005) 0.97
Overexpression of inhibitor of DNA-binding (ID)-1 protein related to angiogenesis in tumor advancement of ovarian cancers. BMC Cancer (2009) 0.96
Preventive effect of Juzen-taiho-to on endometrial carcinogenesis in mice is based on Shimotsu-to constituent. Biol Pharm Bull (2004) 0.96
Dissecting the molecular basis of organ of Corti development: Where are we now? Hear Res (2011) 0.95
Expression of estrogen receptor alpha and beta in myometrium of premenopausal and postmenopausal women. Steroids (2003) 0.94
A simple spectrophotometric method for the determination of copper in industrial, environmental, biological and soil samples using 2,5-dimercapto-1,3,4-thiadiazole. Anal Sci (2002) 0.94
Clinical implications of steroid receptor coactivator (SRC)-3 in uterine endometrial cancers. J Steroid Biochem Mol Biol (2007) 0.94
Clinical implications of expression of ETS-1 related to angiogenesis in metastatic lesions of ovarian cancers. Oncology (2004) 0.93
Osteopontin in metastatic lesions as a prognostic marker in ovarian cancers. J Biomed Sci (2007) 0.93
Androgens upregulate Cdc25C protein by inhibiting its proteasomal and lysosomal degradation pathways. PLoS One (2013) 0.91
A mutation in the Srrm4 gene causes alternative splicing defects and deafness in the Bronx waltzer mouse. PLoS Genet (2012) 0.91
Evolution and development of the tetrapod auditory system: an organ of Corti-centric perspective. Evol Dev (2013) 0.91
Postpartum hemorrhage in coagulopathic patients: preliminary experience with uterine arterial embolization with N-butyl cyanoacrylate. J Vasc Interv Radiol (2011) 0.90
Clinical implication of estrogen-related receptor (ERR) expression in ovarian cancers. J Steroid Biochem Mol Biol (2007) 0.90
Inner ear development: building a spiral ganglion and an organ of Corti out of unspecified ectoderm. Cell Tissue Res (2014) 0.89
Penetration of ravuconazole, a new triazole antifungal, into rat tissues. Chemotherapy (2002) 0.89
Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers. Gynecol Oncol (2009) 0.87
Noise statistics of phase-resolved optical coherence tomography imaging: single-and dual-beam-scan Doppler optical coherence tomography. Opt Express (2014) 0.86
Atoh1 directs hair cell differentiation and survival in the late embryonic mouse inner ear. Dev Biol (2013) 0.86
Sex steroid-dependent angiogenesis in uterine endometrial cancers. J Steroid Biochem Mol Biol (2005) 0.86
Tandem repeat sequences evolutionarily related to SVA-type retrotransposons are expanded in the centromere region of the western hoolock gibbon, a small ape. J Hum Genet (2012) 0.85
Overview of essential tremor. Neuropsychiatr Dis Treat (2010) 0.85
Understanding the evolution and development of neurosensory transcription factors of the ear to enhance therapeutic translation. Cell Tissue Res (2012) 0.85
Significant anti-proliferation of human endometrial cancer cells by combined treatment with a selective COX-2 inhibitor NS398 and specific MEK inhibitor U0126. Int J Oncol (2005) 0.84
Translocation of lysophosphatidic acid phosphatase in response to gonadotropin-releasing hormone to the plasma membrane in ovarian cancer cell. Am J Obstet Gynecol (2004) 0.83
Expression of interferon-gamma-inducible protein 10 related to angiogenesis in uterine endometrial cancers. Oncology (2008) 0.82
Clinical implications of osteopontin in metastatic lesions of uterine cervical cancers. Cancer Lett (2006) 0.82
Drastic decrease of progesterone receptor form B but not A mRNA reflects poor patient prognosis in endometrial cancers. Gynecol Oncol (2004) 0.82
Steroids up-regulate p66Shc longevity protein in growth regulation by inhibiting its ubiquitination. PLoS One (2011) 0.82
Clinical implications of expression of ETS-1 in relation to angiogenesis in ovarian cancers. Cancer Sci (2003) 0.82
Estrogen-related receptor expression in placenta throughout gestation. J Steroid Biochem Mol Biol (2005) 0.82
MR imaging findings of uterine pyomyoma: radiologic-pathologic correlation. Abdom Imaging (2014) 0.82
Anti-tumor effects of herbal medicines on endometrial carcinomas via estrogen receptor-alpha-related mechanism. Oncol Rep (2006) 0.81
Evolving gene regulatory networks into cellular networks guiding adaptive behavior: an outline how single cells could have evolved into a centralized neurosensory system. Cell Tissue Res (2014) 0.81
Direct protection by a gonadotropin-releasing hormone analog from doxorubicin-induced granulosa cell damage. Gynecol Obstet Invest (2006) 0.81
Correct timing of proliferation and differentiation is necessary for normal inner ear development and auditory hair cell viability. Dev Dyn (2013) 0.80
Expression of cyclooxygenase-2 related to angiogenesis in uterine cervical cancers. J Biomed Sci (2006) 0.80
Clinical implications of the expression of estrogen receptor-alpha and -beta in primary and metastatic lesions of uterine endometrial cancers. Oncology (2002) 0.80
Multisite, double-blind, randomized, controlled study of pregabalin for essential tremor. Mov Disord (2012) 0.80
Penetration into and exposure of cefozopran in pelvic retroperitoneal space exudate. J Infect Chemother (2008) 0.80
[Two cases of Bartholin's gland abscesses caused by Streptococcus pneumoniae and Haemophilus influenzae]. Jpn J Antibiot (2005) 0.80
Uterine contractions might increase heart preload in the recipient fetus in early-onset twin-twin transfusion syndrome: an ultrasound assessment. Prenat Diagn (2004) 0.80
Gonadotrophin-releasing hormones agonist therapy increases peritoneal fibrinolytic activity and prevents adhesion formation after myomectomy. J Obstet Gynaecol (2003) 0.79
Expression of ETS-1 related to angiogenesis in uterine endometrium during the menstrual cycle. J Biomed Sci (2003) 0.79
Leptin as an acute stress-related hormone in the fetoplacental circulation. Obstet Gynecol (2002) 0.78
Intravaginal bacterial flora in patients with uterine cervical cancer. High incidence of detection of Gardnerella vaginalis. J Infect Chemother (1999) 0.78
PTEN sensitizes epidermal growth factor-mediated proliferation in endometrial carcinoma cells. Oncol Rep (2006) 0.78
Intratumoral level of gonadotropin-releasing hormone in ovarian and endometrial cancers. Oncol Rep (2002) 0.78
Role of inhibitor of DNA binding-1 protein is related to angiogenesis in the tumor advancement of uterine endometrial cancers. Exp Ther Med (2010) 0.78
[Prevalence and treatment of pharyngeal Chlamydia trachomatis infections]. Jpn J Antibiot (2006) 0.78
Analysis of estrogen receptor expression in tissues. Methods Enzymol (2003) 0.78
Clinical efficacy of clarithromycin against uterine cervical and pharyngeal Chlamydia trachomatis and the sensitivity of polymerase chain reaction to detect C. trachomatis at various time points after treatment. J Infect Chemother (2003) 0.78
Plausible linkage of hypoxia-inducible factor (HIF) in uterine endometrial cancers. Oncology (2007) 0.78
Cavernous lymphangioma arising from uterine corpus. Gynecol Oncol (2003) 0.77
Independent action of serine/threonine protein phosphatase in ovarian cancer plasma membrane and cytosol during gonadotropin-releasing hormone stimulation. Oncol Rep (2003) 0.77
MRI during pregnancy. J Perinat Med (2003) 0.77
Membrane-associated serine/threonine protein phosphatase in endometrial cancer. Am J Obstet Gynecol (2003) 0.77
Plausible linkage of hypoxia inducible factor-1alpha in uterine cervical cancer. Cancer Sci (2006) 0.77
Shimotsu-to is the agent in Juzen-taiho-to responsible for the prevention of endometrial carcinogenesis in mice. Cancer Lett (2002) 0.77
Expression of protease activated receptor-2 related to angiogenesis in tumor advancement of uterine endometrial cancers. Oncol Rep (2007) 0.77